Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 16, 2008

ZyGEM and Advalytix to Develop DNA Extraction Products

  • ZyGEM and the Advalytix product team of Olympus Life Science Research Europa are working together to produce a private-label line of DNA extraction products. ZyGEM's enzymatic nucleic acid extraction technology will be coupled with Advalytix' expertise in single-cell molecular tests for life science research and diagnostic applications.

    Advalytix will market private-label DNA extraction products based on ZyGEM's temperature-controlled extraction (TEC) technology. The kits will be designed to work with Advalytix' single-cell molecular diagnostics and its miniaturized diagnostic and biological tests for R&D.

    ZyGEM's DNA extraction technology uses a thermophilic enzyme to extract DNA from samples using a single closed-tube system. This approach reportedly simplifies laboratory workflow, minimizes error, reduces the risk of contamination, and ensures sample integrity while also reducing costs.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »